Plasmodium falciparum phosphatidylinositol 4-kinase beta

Home
Targets
Other protein targets
Anti-infective targets
Antimalarial targets
Kinases (Plasmodium spp.)
Plasmodium falciparum phosphatidylinositol 4-kinase beta

Target not currently curated in GtoImmuPdb

Malaria Pharmacology Ligand Target has curated data in GtoMPdb

Target id: 2972

Nomenclature: Plasmodium falciparum phosphatidylinositol 4-kinase beta

Abbreviated Name: PfPI4Kβ

Gene and Protein Information
Species	TM	AA	Chromosomal Location	Gene Symbol	Gene Name	Reference
Plasmodium falciparum 3D7	-	1559		PI4KB	phosphatidylinositol 4-kinase beta
Gene and Protein Information Comments
Our phosphatidylinositol 4-kinase beta summary page provides information about the closest human orthologue (~43% shared sequence identity).

Previous and Unofficial Names
PI4KB \| Pf3D7_05_v3:409,403..415,758(+) \| phosphatidylinositol 4-kinase \| phosphatidylinositol 4-kinase type III beta \| PI4K \| PI4KIIIβ \| PI4KIIIbeta \| PFE0485w

Previous and Unofficial Names

Database Links
Alphafold	Q8I406 (Pf3D7)
PlasmoDB	PF3D7_0509800 (Pf3D7)
UniProtKB	Q8I406 (Pf3D7)

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors

Key to terms and symbols

View all chemical structures

Click column headers to sort

Ligand		Sp.	Action	Value	Parameter	Reference
CHMFL-PI4K-127		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Inhibition	9.1	pIC₅₀	4
⤷	pIC₅₀ 9.1 (IC₅₀ 9x10^-10 M) [4]
NCATS-SM3710		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Inhibition	8.7	pIC₅₀	3
⤷	pIC₅₀ 8.7 (IC₅₀ 2x10^-9 M) [3]

Other Binding Ligands

Key to terms and symbols

Click column headers to sort

Ligand											Sp.	Action	Value	Parameter	Reference
MMV048											Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Binding	6.5 – 7.0	pK_d	6
⤷	pK_d 7.0 (K_d 1x10^-7 M) [6] pK_d 6.5 (K_d 3x10^-7 M) [6]

Whole Organism Assay Data Linked to This Target

Key to terms and symbols

Click column headers to sort

Ligand		Sp.	Assay description	Type	Action	Value	Parameter	Reference
NCATS-SM3710		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	9.4	pEC₅₀	3
⤷	pEC₅₀ 9.4 (EC₅₀ 3.8x10^-10 M) Viability measured using MitoProbe DiIC1(5) staining and flow cytometry [3] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
NCATS-SM3710		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Parasite late stage (IV–V) gametocyte assay	-	-	8.2	pEC₅₀	3
⤷	pEC₅₀ 8.2 (EC₅₀ 5.77x10^-9 M) Viability measured using MitoProbe DiIC1(5) staining and flow cytometry [3] Lifecycle stages: Plasmodium sexual blood stage (gametocyte)
CHMFL-PI4K-127		Pf3D7 Plasmodium falciparum 3D7 P. falciparum strain 3D7 (Pf3D7) was derived from isolate NF54 by limiting dilution. The complete genome of Pf3D7 has been sequenced (GenBank: LN999946.1). Pf3D7 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	7.6	pEC₅₀	4
⤷	pEC₅₀ 7.6 (EC₅₀ 2.51x10^-8 M) SYBR Green I assay [4] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
CHMFL-PI4K-127		PfDd2 Plasmodium falciparum Dd2 P. falciparum strain Dd2 (PfDd2) is a clone derived from PfW2, following continuous culture in mefloquine. PfW2 was cloned from the Indochina III/CDC isolate, originally derived from a Laotian patient who failed chloroquine therapy. PfDd2 can be obtained from the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be resistant to chloroquine, pyrimethamine and mefloquine. ✖	Parasite growth inhibition assay	-	-	7.5	pEC₅₀	4
⤷	pEC₅₀ 7.5 (EC₅₀ 3.03x10^-8 M) SYBR Green I assay [4] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		Pb Plasmodium berghei P. berghei (Pb) is a malaria parasite that infects mammals other than humans with the natural mammalian host being the thicket rat (G. surdaster) from Central Africa. Pb is used in rodent model studies of malaria. ✖	Parasite liver stage assay	-	-	9.0	pIC₅₀	1
⤷	pIC₅₀ 9.0 (IC₅₀ 9.2x10^-10 M) Luciferase bioluminescence assay to measure sporozoite invasion (prophylactic activity) [1] Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite)
UCT943		PfHB3 Plasmodium falciparum HB3 P. falciparum strain HB3 (PfHB3) was cloned from the Honduras I/CDC strain, originally isolated from a patient in Choluteca, Honduras, during an outbreak of urban malaria in January 1980. PfHB3 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be chloroquine sensitive. ✖	Parasite growth inhibition assay	-	-	8.4	pIC₅₀	1
⤷	pIC₅₀ 8.4 (IC₅₀ 3.7x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		Pf7G8 Plasmodium falciparum 7G8 P. falciparum strain 7G8 (Pf7G8) was subcloned from the IMTM22 strain by limiting dilution. The original IMTM22 strain was isolated from a 12 year old male near Manaus, Brazil in 1980. Pf7G8 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4). This strain is a gametocyte producer and is reported to be chloroquine-sensitive and pyrimethamine-resistant. ✖	Parasite growth inhibition assay	-	-	8.4	pIC₅₀	1
⤷	pIC₅₀ 8.4 (IC₅₀ 4.1x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		PfV1/S Plasmodium falciparum V1/S P. falciparum strain V1/S (PfV1/S) is an in vitro culture-adapted clone of V1, that originated in Vietnam. PfV1/S can be obtained from the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be resistant to chloroquine and quinine. ✖	Parasite growth inhibition assay	-	-	8.4	pIC₅₀	1
⤷	pIC₅₀ 8.4 (IC₅₀ 4.2x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		PfK1 Plasmodium falciparum K1 P. falciparum strain K1 (PfK1) was isolated in Kanchanaburi, Thailand in 1979. PfK1 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be a multidrug-resistant strain. ✖	Parasite growth inhibition assay	-	-	8.3	pIC₅₀	1
⤷	pIC₅₀ 8.3 (IC₅₀ 4.7x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		PfD6 Plasmodium falciparum D6 P. falciparum strain D6 (PfD6) was collected in Sierra Leone. PfD6 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is generally considered drug sensitive with minor mefloquine resistance. ✖	Parasite growth inhibition assay	-	-	8.3	pIC₅₀	1
⤷	pIC₅₀ 8.3 (IC₅₀ 5.2x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	8.3	pIC₅₀	1
⤷	pIC₅₀ 8.3 (IC₅₀ 5.4x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		PfDd2 Plasmodium falciparum Dd2 P. falciparum strain Dd2 (PfDd2) is a clone derived from PfW2, following continuous culture in mefloquine. PfW2 was cloned from the Indochina III/CDC isolate, originally derived from a Laotian patient who failed chloroquine therapy. PfDd2 can be obtained from the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be resistant to chloroquine, pyrimethamine and mefloquine. ✖	Parasite growth inhibition assay	-	-	8.2	pIC₅₀	1
⤷	pIC₅₀ 8.2 (IC₅₀ 5.7x10^-9 M) [³H]-hypoxanthine incorporation [1] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		Pc Plasmodium cynomolgi P. cynomolgi (Pc) is a malaria parasite that infects non-human primate species with the natural mammalian host being Asian Old World monkeys. Pc is used as a model for human P. vivax infection because these species are phylogenetically close and share a similar lifecycle, including the dormant liver form (hypnozoite). ✖	Parasite liver stage assay	-	-	>8.0	pIC₅₀	1
⤷	pIC₅₀ >8.0 (IC₅₀ <1x10^-8 M) P. cynomolgi assay to assess inhibition of liver stage development (prophylactic activity) [1] Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite)
MMV048		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	7.6	pIC₅₀	6
⤷	pIC₅₀ 7.6 (IC₅₀ 2.8x10^-8 M) [³H]-hypoxanthine incorporation assay [6] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
KDU691		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Parasite growth inhibition assay	-	-	7.5	pIC₅₀	5
⤷	pIC₅₀ 7.5 (IC₅₀ 2.99x10^-8 M) SYBR Green assay [5] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
KDU691		Py Plasmodium yoelii P. yoelii (Py) is a malaria parasite that infects mammals other than humans with the natural mammalian host being the thicket rat (G. surdaster) from Central Africa. Py is used in rodent model studies of malaria, in particular the immune response and in vaccine development. ✖	Parasite liver stage assay	-	-	7.4	pIC₅₀	5
⤷	pIC₅₀ 7.4 (IC₅₀ 3.6x10^-8 M) Sporozoite hepatocyte invasion assay [5] Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite)
compound 55 [PMID: 29889526]		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	7.2	pIC₅₀	2
⤷	pIC₅₀ 7.2 (IC₅₀ 6.3x10^-8 M) Parasite lactate dehydrogenase (pLDH ) assay [2] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
UCT943		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Parasite dual gamete formation assay (DGFA)	-	-	7.1	pIC₅₀	1
⤷	pIC₅₀ 7.1 (IC₅₀ 8x10^-8 M) Reports on the functional viability of male and female mature stage V gametocytes [1] Lifecycle stages: Plasmodium mosquito host stage (gametocyte, gamete, zygote, ookinete, oocyst, sporozoite)
UCT943		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Parasite gametocyte viability assay	-	-	6.9 – 7.2	pIC₅₀	1
⤷	pIC₅₀ 7.2 (IC₅₀ 6.6x10^-8 M) Parasite late stage (IV-V) gametocyte assay using luciferase reporter line [1] Lifecycle stages: Plasmodium sexual blood stage (gametocyte) pIC₅₀ 6.9 (IC₅₀ 1.34x10^-7 M) Parasite early stage (I-III) gametocyte assay using luciferase reporter line [1] Lifecycle stages: Plasmodium sexual blood stage (gametocyte)
UCT943		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Standard membrane feeding assay (SMFA)	-	-	7.0	pIC₅₀	1
⤷	pIC₅₀ 7.0 (IC₅₀ 9.6x10^-8 M) [1] Lifecycle stages: Plasmodium mosquito host stage (gametocyte, gamete, zygote, ookinete, oocyst, sporozoite)
compound 55 [PMID: 29889526]		PfK1 Plasmodium falciparum K1 P. falciparum strain K1 (PfK1) was isolated in Kanchanaburi, Thailand in 1979. PfK1 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is reported to be a multidrug-resistant strain. ✖	Parasite growth inhibition assay	-	-	7.0	pIC₅₀	2
⤷	pIC₅₀ 7.0 (IC₅₀ 1.02x10^-7 M) Parasite lactate dehydrogenase (pLDH ) assay [2] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
MMV048		Pf Plasmodium falciparum P. falciparum (Pf) is one of five protozoan parasite species of the genus Plasmodium that cause malaria in humans. Pf is responsible for the majority of malaria related deaths and is the most prevalent species in sub-Saharan Africa. ✖	Standard membrane feeding assay (SMFA)	-	-	6.9	pIC₅₀	6
⤷	pIC₅₀ 6.9 (IC₅₀ 1.11x10^-7 M) Indirect SMFA [6] Lifecycle stages: Plasmodium mosquito host stage (gametocyte, gamete, zygote, ookinete, oocyst, sporozoite)
KDU691		Pc Plasmodium cynomolgi P. cynomolgi (Pc) is a malaria parasite that infects non-human primate species with the natural mammalian host being Asian Old World monkeys. Pc is used as a model for human P. vivax infection because these species are phylogenetically close and share a similar lifecycle, including the dormant liver form (hypnozoite). ✖	Parasite liver stage assay	-	-	~6.7	pIC₅₀	5
⤷	pIC₅₀ ~6.7 (IC₅₀ ~1.96x10^-7 M) P. cynomolgi infected primary rhesus hepatocyte assay to assess activity against hypnozoites [5] Lifecycle stages: Plasmodium dormant liver stage (hypnozoite)
MMV048		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite gametocyte viability assay	-	-	6.6 – 6.8	pIC₅₀	6
⤷	pIC₅₀ 6.8 (IC₅₀ 1.4x10^-7 M) Parasite late stage (IV-V) gametocyte assay using luciferase reporter line [6] Lifecycle stages: Plasmodium sexual blood stage (gametocyte) pIC₅₀ 6.7 (IC₅₀ 2.14x10^-7 M) Parasite early stage (I-III) gametocyte assay using luciferase reporter line [6] Lifecycle stages: Plasmodium sexual blood stage (gametocyte) pIC₅₀ 6.6 (IC₅₀ 2.85x10^-7 M) Parasite late stage (IV-V) gametocyte assay: parasitic lactate dehydrogenase (pLDH) assay [6] Lifecycle stages: Plasmodium sexual blood stage (gametocyte)
KDU691		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite late stage (III–V) gametocyte assay	-	-	6.7	pIC₅₀	5
⤷	pIC₅₀ 6.7 (IC₅₀ 2.2x10^-7 M) Parasite lactate dehydrogenase (pLDH) assay [5] Lifecycle stages: Plasmodium sexual blood stage (gametocyte)
MMV024101		PfNF54 Plasmodium falciparum NF54 P. falciparum strain NF54 (PfNF54) was derived from a patient who had never left the Netherlands. PfNF54 can be obtained from the European Malaria Reagent Repository or the Malaria Research and Reference Reagent Resource Center (MR4) and is sensitive to a panel of antimalarial compounds including chloroquine and pyrimethamine. ✖	Parasite growth inhibition assay	-	-	6.3	pIC₅₀	2
⤷	pIC₅₀ 6.3 (IC₅₀ 5.43x10^-7 M) Parasite lactate dehydrogenase (pLDH ) assay [2] Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
MMV048		Pc Plasmodium cynomolgi P. cynomolgi (Pc) is a malaria parasite that infects non-human primate species with the natural mammalian host being Asian Old World monkeys. Pc is used as a model for human P. vivax infection because these species are phylogenetically close and share a similar lifecycle, including the dormant liver form (hypnozoite). ✖	Parasite liver stage assay	-	-	<5.0 – 7.2	pIC₅₀	6
⤷	pIC₅₀ 7.2 (IC₅₀ 6.1x10^-8 M) P. cynomolgi assay to assess inhibition of liver stage development (prophylactic activity) [6] Lifecycle stages: Plasmodium dormant liver stage (hypnozoite) pIC₅₀ 7.2 (IC₅₀ 6.4x10^-8 M) P. cynomolgi assay to assess inhibition of liver stage development (prophylactic activity) [6] Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite) pIC₅₀ <5.0 (IC₅₀ >1x10^-5 M) P. cynomolgi assay to assess elimination of hypnozoites (potential as a radical cure) [6] Lifecycle stages: Plasmodium dormant liver stage (hypnozoite)

Malaria Pharmacology Comments
The Plasmodium lipid kinase, phosphatidylinositol-4 kinase (PfPI4K), was first identified as the target of the imidazopyrazines, a novel class of experimental antimalarial compounds that have been shown to be active in multiple Plasmodium spp. and at each stage of malaria infection in the vertebrate host [5]. This study also reported that the imidazopyrazines act through inhibitory interaction with the ATP-binding pocket of the kinase and proposed that PfPI4K acts at the Golgi to regulate essential membrane trafficking events.

Malaria Pharmacology Comments

The Plasmodium lipid kinase, phosphatidylinositol-4 kinase (PfPI4K), was first identified as the target of the imidazopyrazines, a novel class of experimental antimalarial compounds that have been shown to be active in multiple Plasmodium spp. and at each stage of malaria infection in the vertebrate host [5]. This study also reported that the imidazopyrazines act through inhibitory interaction with the ATP-binding pocket of the kinase and proposed that PfPI4K acts at the Golgi to regulate essential membrane trafficking events.

References

Show »« Hide

1. Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT et al.. (2018) UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. Antimicrob Agents Chemother, 62 (9). [PMID:29941635]

2. Kandepedu N, Gonzàlez Cabrera D, Eedubilli S, Taylor D, Brunschwig C, Gibhard L, Njoroge M, Lawrence N, Paquet T, Eyermann CJ et al.. (2018) Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria. J Med Chem, 61 (13): 5692-5703. [PMID:29889526]

3. Krishnan K, Ziniel P, Li H, Huang X, Hupalo D, Gombakomba N, Guerrero SM, Dotrang T, Lu X, Caridha D et al.. (2020) Torin 2 Derivative, NCATS-SM3710, Has Potent Multistage Antimalarial Activity through Inhibition of P. falciparum Phosphatidylinositol 4-Kinase (Pf PI4KIIIβ). ACS Pharmacol Transl Sci, 3 (5): 948-964. [PMID:33073193]

4. Liang X, Jiang Z, Huang Z, Li F, Chen C, Hu C, Wang W, Hu Z, Liu Q, Wang B et al.. (2020) Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. Eur J Med Chem, 188: 112012. [PMID:31911293]

5. McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ et al.. (2013) Targeting Plasmodium PI(4)K to eliminate malaria. Nature, 504 (7479): 248-253. [PMID:24284631]

6. Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MCS, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ et al.. (2017) Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Transl Med, 9 (387). [PMID:28446690]

How to cite this page

Kinases (Plasmodium spp.): Plasmodium falciparum phosphatidylinositol 4-kinase beta. Last modified on 21/02/2022. Accessed on 18/04/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2972.

Plasmodium falciparum phosphatidylinositol 4-kinase beta

Contents:

Plasmodium falciparum

Plasmodium falciparum

Plasmodium falciparum

Plasmodium falciparum NF54

Plasmodium falciparum

Plasmodium falciparum 3D7

Plasmodium falciparum Dd2

Plasmodium berghei

Plasmodium falciparum HB3

Plasmodium falciparum 7G8

Plasmodium falciparum V1/S

Plasmodium falciparum K1

Plasmodium falciparum D6

Plasmodium falciparum NF54

Plasmodium falciparum Dd2

Plasmodium cynomolgi

Plasmodium falciparum NF54

Plasmodium falciparum

Plasmodium yoelii

Plasmodium falciparum NF54

Plasmodium falciparum

Plasmodium falciparum

Plasmodium falciparum

Plasmodium falciparum K1

Plasmodium falciparum

Plasmodium cynomolgi

Plasmodium falciparum NF54

Plasmodium falciparum NF54

Plasmodium falciparum NF54

Plasmodium cynomolgi

References

How to cite this page